Gf-Fund-Management-Co

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-29
Total Holdings
666
Total Value
4262829836
Accession Number
0002057060-25-000003
Form Type
13F-HR
Manager Name
Gf-Fund-Management-Co
Data Enrichment
99% identified
658 identified8 unidentified

Holdings

666 positions • $4.3B total value
Manager:
Search and click to pin securities to the top
Page 33 of 34
Alector, Inc.
Shares:2.4K
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$4.3B)
ENANTA PHARMACEUTICALS INC
Shares:525
Value:$2.9K
% of Portfolio:0.0% ($2.9K/$4.3B)
Lexeo Therapeutics, Inc.
Shares:820
Value:$2.8K
% of Portfolio:0.0% ($2.8K/$4.3B)
C4 Therapeutics, Inc.
Shares:1.8K
Value:$2.8K
% of Portfolio:0.0% ($2.8K/$4.3B)
Editas Medicine, Inc.
Shares:2.1K
Value:$2.5K
% of Portfolio:0.0% ($2.5K/$4.3B)
FATE THERAPEUTICS INC
Shares:2.7K
Value:$2.2K
% of Portfolio:0.0% ($2.2K/$4.3B)
Kyverna Therapeutics, Inc.
Shares:1.1K
Value:$2.1K
% of Portfolio:0.0% ($2.1K/$4.3B)
PLIANT THERAPEUTICS, INC.
Shares:1.5K
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$4.3B)
MACROGENICS INC
Shares:1.6K
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$4.3B)
28658R106
Shares:1.6K
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$4.3B)
Biomea Fusion, Inc.
Shares:899
Value:$1.9K
% of Portfolio:0.0% ($1.9K/$4.3B)
Hewlett Packard Enterprise Co
Shares:123
Value:$1.9K
% of Portfolio:0.0% ($1.9K/$4.3B)
Artiva Biotherapeutics, Inc.
Shares:603
Value:$1.8K
% of Portfolio:0.0% ($1.8K/$4.3B)
TScan Therapeutics, Inc.
Shares:1.2K
Value:$1.7K
% of Portfolio:0.0% ($1.7K/$4.3B)
Acrivon Therapeutics, Inc.
Shares:772
Value:$1.6K
% of Portfolio:0.0% ($1.6K/$4.3B)
Inozyme Pharma, Inc.
Shares:1.5K
Value:$1.4K
% of Portfolio:0.0% ($1.4K/$4.3B)
Pyxis Oncology, Inc.
Shares:1.4K
Value:$1.4K
% of Portfolio:0.0% ($1.4K/$4.3B)
OnKure Therapeutics, Inc.
Shares:313
Value:$1.3K
% of Portfolio:0.0% ($1.3K/$4.3B)
SUTRO BIOPHARMA, INC.
Shares:2.0K
Value:$1.3K
% of Portfolio:0.0% ($1.3K/$4.3B)
PepGen Inc.
Shares:808
Value:$1.1K
% of Portfolio:0.0% ($1.1K/$4.3B)